Use of pre S containing Hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for Hepatitis B virus chronic infection.
SCIE
SCOPUS
- Title
- Use of pre S containing Hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for Hepatitis B virus chronic infection.
- Authors
- Yum, JS; Ahn, BC; Jo, HJ; Kim, DY; Kim, KH; Kim, HS; Sung, YC; Yoon, J; Morrey, J; Moon, HM
- Date Issued
- 2012-02
- Publisher
- American society for microbiology
- Abstract
- A hepatitis B virus (HBV) vaccine has been developed using a new adjuvant and HBV surface antigens produced from a CHO cell line. The purified HBV surface antigens are composed of L protein, Mprotein, and S protein in a mixture of 20- and 40-nm-diameter particles and filamentous forms. This HBV surface antigen, formulated with L-pampo, a proprietary adjuvant, induced 10 times more antibody than the same antigen with alum and was capable of inducing strong immune responses in three different HBV transgenic mice. In spite of the presence of a large amount of HBV antigen in the blood, no antibody against HBV surface antigen was normally detected in these transgenic mice. After immunization, the HBV antigen was also cleared from the blood.
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/10065
- DOI
- 10.1128/CVI.05355-11
- ISSN
- 1556-6811
- Article Type
- Article
- Citation
- CLINICAL AND VACCINE IMMUNOLOGY, vol. 19, no. 2, page. 120 - 127, 2012-02
- Files in This Item:
-
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.